TRAF3IP2 Polyclonal Antibody

TRAF3IP2 Polyclonal Antibody

The TRAF3IP2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of TRAF3IP2 protein expression in various biological samples. This antibody has been meticulously developed using advanced immunization techniques and exhibits exceptional sensitivity and specificity.

TRAF3IP2, also known as Act1, is a crucial adaptor protein involved in the regulation of various signaling pathways, including those mediated by Toll-like receptors (TLRs) and Interleukin-17 (IL-17) family cytokines. It plays a pivotal role in the activation of nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling cascades, thereby influencing immune responses and inflammatory processes.

The TRAF3IP2 Polyclonal Antibody has been extensively validated for its performance in multiple applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits exceptional specificity, ensuring accurate and reliable detection of TRAF3IP2 protein expression in a variety of cell and tissue types.

This antibody is produced using high-quality materials and undergoes rigorous quality control measures to ensure batch-to-batch consistency and reproducibility. It is supplied as a liquid formulation in a convenient size, allowing for easy handling and storage.

In summary, the TRAF3IP2 Polyclonal Antibody is a valuable research tool for scientists studying the intricate mechanisms of immune regulation and inflammation. Its exceptional specificity, sensitivity, and reliability make it an indispensable asset for investigating the role of TRAF3IP2 in various physiological and pathological processes.